Eva Arlander rekryteras av Index Pharmaceuticals

Läkemedelsutvecklaren Index Pharmaceuticals har anställt Eva Arlander som Chief Development Officer och medlem i bolagets nya ledningsgrupp. Samtidigt genomförs...

Lillys fetmaläkemedel godkänns mot sömnapné i USA – men inte i EU

Viktminskningsläkemedlet Zepbound (tirzepatid) godkänns av den amerikanska läkemedelsmyndigheten FDA som den första läkemedelsbehandlingen för måttlig till svår...

HAB Nicolai Johannsen

What will be the next big hype after obesity? – An expert panel highlighted their top picks

What will be the next big trend in life science? Everything from Alzheimer’s, Crispr and Omics were highlighted when the issue was debated at this year’s major ...

Digital Temperature Sensors from ZEISS

New Metrology Expert Tip video.

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

The life science strategy – what the industry wants

The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...

A new giant among our microscopes

Two technologies in one machine.

EMA varnar för icke godkända cellterapier

Icke godkända, och därmed olagliga, avancerade terapiläkemedel marknadsförs till patienter i Europa. Det uppger den europeiska läkemedelsmyndigheten EMA, som nu...

NorthX Biologics Matfors AB

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Läkemedelsbolag skänker nödläkemedel till marburgdrabbade Rwanda

Gilead Sciences har beslutat att skänka 5 000 doser av antivirusläkemedlet remdesivir till Rwanda för nödanvändning under det pågående utbrottet av den fruktade...

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Sutro sparkar vd och varslar halva personalstyrkan

Sutro Biopharma genomför ett omfattande besparingspaket efter att ha nedprioriterat ett projekt inom äggstockscancer. Bolagets vd sparkas och halva personalen v...

RegFile AB

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

An increasing number of people are falling ill with TBE – “Much more research is needed”

Tick-borne meningitis, or TBE, is an increasingly common disease in Sweden. Currently, there is a vaccine against the disease but no drugs. Researcher Anna Över...

CTR förvärvar Lundabolag inom topikala läkemedel

Bolagsgruppen Center for Translational Research, CTR, utökar sin portfölj genom förvärv av kontraktsforskningsbolaget Zelmic.

Automate E2E Image Analysis Pipelines

ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.

Easy integration of piezo valves for gas handling

Extremely energy-saving, silent and without any heat build-up – piezo technology offers many benefits for efficient and precise gas handling in medical technolo...

Bioarctic granted Japanese patent for Parkinson’s disease candidate

Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.